IMPAX Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.06.18	Powersports Support® Integrates with RLM Distribution (PR Newswire)
07.05.18	ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax (PR Newswire)
07.05.18	Amneal and Impax Complete Business Combination (PR Newswire)
03.05.18	Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600 (PR Newswire)
28.04.18	Amneal And Impax Receive FTC Clearance For Business Combination (PR Newswire)
28.04.18	ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax (PR Newswire)
10.04.18	PSS Launches Groundbreaking Work Zone Safety Innovation (PR Newswire)
06.04.18	Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) (PR Newswire)
27.03.18	Impax Shareholders Approve Proposed Business Combination with Amneal (PR Newswire)
14.03.18	Amneal Gains Approval for Erythromycin Tablets USP (PR Newswire)
07.03.18	Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference (PR Newswire)
06.03.18	Amneal Pharmaceuticals, LLC -- Moody's rates Amneal's new term loan B1; outlook revised to positive (Moodys)
01.03.18	Amneal Launches Generic for Tamiflu® Oral Suspension (PR Newswire)
01.03.18	Impax Reports Fourth Quarter and Full Year 2017 Results (PR Newswire)
21.02.18	Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR® (PR Newswire)
20.02.18	Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets (PR Newswire)
06.02.18	Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations (PR Newswire)
05.02.18	Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta® (PR Newswire)
01.02.18	Amneal Introduces Isotretinoin Capsules, USP (PR Newswire)
30.01.18	CorePharma, LLC Acquired by Investor Group (PR Newswire)
24.01.18	Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream (PR Newswire)
16.01.18	Impax to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018 (PR Newswire)
19.12.17	Impax Announces Sale of Taiwan Manufacturing Facility (PR Newswire)
18.12.17	Robert Stewart to Join Amneal Pharmaceuticals as President (PR Newswire)
13.12.17	GLYC On The Move, ATNX Rises On KX2-391 Deal, Three Cheers For PTI (RTTNews)
08.12.17	Impax Receives Tentative FDA Approval of Generic Coreg CR® (Carvedilol Phosphate) Extended-Release Capsules (PR Newswire)
01.12.17	SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Impax Laboratories, Inc. - IPXL (PR Newswire)
09.11.17	Impax Reports Third Quarter 2017 Results (PR Newswire)
08.11.17	Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly (PR Newswire)
24.10.17	Wolf Popper LLP Investigates the Proposed Acquisition of Impax Laboratories, Inc. by Amneal Pharmaceuticals LLC (PR Newswire)
23.10.17	Impax Announces FDA Approval and Launch of Generic Renvela® (Sevelamer Carbonate) Tablets, 800 mg (PR Newswire)
19.10.17	SPPI Breathes Easy On Trial Results, PTI Awaits Data In Q4, HAIR Keeps Receding (RTTNews)
17.10.17	Impac Secured Assets Corp. Mortgage Pass-Through Certificates, Series 2006-5 -- Moody's places Impax's ratings under review for upgrade following Amneal merger announcement (Moodys)
17.10.17	Amneal Pharmaceuticals, LLC -- Moody's affirms Amneal's B1 CFR; outlook stable (Moodys)
17.10.17	Impax Under Pressure After Announcing Merger With Amneal (RTTNews)
17.10.17	Amneal Pharma, Impax Announce Business Combination - Quick Facts (RTTNews)
17.10.17	Amneal And Impax To Combine (PR Newswire)
03.10.17	Impax to Report Third Quarter 2017 Results on November 9, 2017 (PR Newswire)
22.09.17	IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns (RTTNews)
19.09.17	Impax to Present at the Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
05.09.17	Impax to Present at the Morgan Stanley 15th Annual Global Healthcare Conference (PR Newswire)
01.09.17	IPXL Reveals Oriental Stakeholder, LENS Has A Vision, STDY Is Very Shaky (RTTNews)
29.08.17	Technical Reports on Drug Makers Equities -- Impax Labs, GlaxoSmithKline, Novartis, and TherapeuticsMD (PR Newswire)
11.08.17	Gainers & Losers Of Aug.10: SGMO, VTVT, EDIT, ACRS, CEMP... (RTTNews)
07.08.17	Impax Announces Settlement of Contract Litigation on Opana® ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets (PR Newswire)
20.07.17	Technical Reports on Drug Makers Equities -- TherapeuticsMD, GlaxoSmithKline, Novartis, and Impax Labs (PR Newswire)
18.07.17	Biotech Stocks Growing Faster Than Other Sectors Fueled by Breakthroughs in R&D and Clinical Trials (PR Newswire)
18.07.17	Biotech Stocks Growing Faster Than Other Sectors Fueled by Breakthroughs in R&D and Clinical Trials (PR Newswire)
18.07.17	Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN... (RTTNews)
17.07.17	Impax Announces FDA Approval of its AB Rated Generic Concerta® (Methylphenidate Hydrochloride) Extended-Release Tablets CII (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu IMPAX Laboratories Inc.

Aktien Top/Flop

Meistgelesene Nachrichten